Navigation Links
MiMedx Group Announces Temporary Trading Symbol Designation
Date:2/22/2010

ATLANTA, Feb. 22 /PRNewswire-FirstCall/ -- MiMedx Group, Inc. (OTC Bulletin Board: MDXG) has received numerous inquiries regarding the temporary change of its symbol to "MDXGE.OB" rather than "MDXG.OB".  This resulted from the change of the Company's fiscal year to a calendar year, as reported on form 8-K filed December 21, 2009.  The matter has been resolved and the OTC:BB has advised the Company that its stock will resume trading under "MDXG.OB" on Tuesday, February 23. Until such time, as was the case today, the Company's shares may be traded using the temporary symbol.

About MiMedx Group, Inc.

MiMedx Group, Inc. is an integrated developer, manufacturer and marketer of patent protected biomaterial-based products and is in the process of transitioning from a development-focused concern to an operating company focused on sales growth and profitability. The Company's assets include intellectual property protecting a collagen-based technology for augmentation of soft and connective tissue diseases and trauma and intellectual property protecting a novel durable hydrogel technology. The Company has received FDA clearance for its first durable hydrogel product, the Paradis Vaso Shield ™ indicated for use as a cover for vessels following anterior spinal surgery.

Important Note regarding forward-looking statements and risk factors. This press release includes statements that look forward in time or that express management's beliefs, expectations or hopes. These statements include those regarding the date on which its shares will resume trading under its former symbol. These risks and uncertainties include that the resumption may be delayed due to administrative issues . The risks and uncertainties also include the risk factors detailed in its Securities and Exchange Commission filings, including, without limitation, its 10-K filing for the fiscal year ended March 31, 2009, and its most recent Form 10-Q filed on November 16, 2009. The Company does not undertake to update its forward-looking statements.

SOURCE MiMedx Group, Inc.

Back to top
'/>"/>
SOURCE MiMedx Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MiMedx Group, Inc. Adds Ronald G. Wallace to Board of Directors
2. MiMedx Group Announces Post-split Name Change
3. MiMedx Announces Brian J. Splan as President
4. Alynx, Co. Completes Merger With Medical Device Company MiMedx, Inc.
5. Anpath Group, Inc. Announces Fiscal 2010 Third Quarter Results
6. Encorium Group, Inc. Announces One-for-Eight Reverse Stock Split
7. Invida Selects LaVoie Group as Public Relations Agency of Record
8. Michael Langley, DVM, MBA, RAC Joins the Anson Group as a Regulatory Consultant
9. China YCT International Group, Inc. Announces That the State Intellectual Property Office of the Peoples Republic of China has Approved a Patent to its Operating Subsidiary, Shandong Spring Pharmaceutical Co. Ltd.
10. Danaher Completes Offer for Genetix Group plc
11. Lori Kahler Appointed President of The RC Insight Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... YORK , January 20, 2017 ... Organization, cancer is one of leading causes of death ... 2012. Although the number of cancer related deaths increased ... 1990. Rising in incidence rate of various cancers continues ... to a research report by Global Market Insights, Inc. ...
(Date:1/19/2017)... Jan. 19, 2017  Market Research Future has a half cooked ... Liquid Biopsy is growing rapidly and expected to reach USD 450 ... Highlights ... Liquid Biopsy Market has been assessed as a swiftly growing market ... boom in the coming future. There has been a tremendous growth ...
(Date:1/19/2017)... Research and Markets ... the addition of the "Implantable Biomaterials Market Analysis ... report to their offering. Report Highlights: ... on current and future market trends to identify the investment opportunities ... base numbers Key market trends across the business segments, ...
(Date:1/19/2017)... GAITHERSBURG, Md. , Jan. 19, 2017 /PRNewswire/ ... a privately-held immunotherapeutics company targeting infectious diseases, announced ... the merger of PharmAthene and Altimmune in an ... Fund, HealthCap, Truffle Capital and Redmont Capital. The ... immunotherapeutics company with four clinical stage and one ...
Breaking Biology Technology:
(Date:1/6/2017)... NEWARK, Calif. , Jan. 5, 2017  Delta ... introduced its iris scanning technology for automotive at CESĀ® ... GNTX ) to demonstrate the use of ... to identify and authenticate the driver in a car, ... automobiles during the driving experience. Delta ID ...
(Date:12/22/2016)... NEW YORK , December 22, 2016 ... global provider of secure solutions for the e-Government, Public Safety, HealthCare, ... a subsidiary of SuperCom, has been selected to implement and deploy ... county in Northern California , further expanding its ... ...
(Date:12/16/2016)... 16, 2016 Research and Markets has announced ... Global Forecast to 2021" report to their offering. ... The biometric vehicle access ... a CAGR of 14.06% from 2016 to 2021. The market is ... to reach 854.8 Million by 2021. The growth of the biometric ...
Breaking Biology News(10 mins):